Ignite Creation Date:
2025-12-26 @ 4:03 PM
Ignite Modification Date:
2025-12-30 @ 4:05 PM
Study NCT ID:
NCT06450106
Status:
RECRUITING
Last Update Posted:
2025-06-27
First Post:
2024-06-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
Sponsor:
SURGE Therapeutics
Organization:
Study Overview
Official Title:
A Phase 1 Dose Escalation Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical Prostatectomy
Status:
RECRUITING
Status Verified Date:
2025-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical Prostatectomy
Detailed Description:
A Phase 1 Dose Escalation Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical Prostatectomy
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: